Sort
64,565 grants matching “drug discovery”
Discovery of Antibiotics from Soil Microbiomes Using Metagenomics
$678,000Sean F Brady · Rockefeller University · R35 · FY2020 · GM
Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms
$677,959Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$677,927Danish Saleheen · Columbia University Health Sciences · R01 · FY2022 · DK
Structural Biology & Biophysics Core (SBB)
$677,889Andrew D Mesecar · Indiana University Indianapolis · U54 · FY2025 · AG
UC San Diego Clinical and Translational Research Institute
$677,865Colin A Depp · University Of California, San Diego · TL1 · FY2018 · TR
Single-cell Analysis of Normal and Perturbed Dynamic Biological Systems
$677,833Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Engineered Stem Cells for Cardiac Repair
$677,801Michael Regnier · University Of Washington · R01 · FY2020 · HL
Role of Host Protein Kinase C in Cryptosporidiosis
$677,703Chelsea S. Marie · University Of Virginia · R01 · FY2023 · AI
Salmonella-specific therapeutics
$677,686Brian M Ahmer · Ohio State University · R01 · FY2020 · AI
Nuclear Factor-kappaB in Ovarian Cancer
$677,683Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Designing drugs that suppress chronic brain inflammation
$677,640Inflame Therapeutics, Inc. · R43 · FY2005 · NS
Development Of Drugs Acting At Adenosine Receptors
$677,639Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
$677,532Thota Ganesh · Emory University · UG3 · FY2022 · NS
Development of vector-specific, resistance-breaking insecticides to reduce malari
$677,523Paul R Carlier · Virginia Polytechnic Inst And St Univ · R01 · FY2011 · AI
Pan-filovirus antivirals targeting the VP35 protein
$677,475Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R56 · FY2010 · AI
Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia
$677,289Michael R Savona · Vanderbilt University Medical Center · R01 · FY2025 · CA
Behavioral Phenotyping Core
$677,286Leona Gagnon · Jackson Laboratory · P50 · FY2023 · DA
Positive Allosteric Modulators as PET Imaging Ligans for mGluR4
$677,276Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2019 · NS
Evolution of drug resistance in Candida glabrata
$677,183Gavin J Sherlock · Stanford University · R01 · FY2021 · AI
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
$677,137Peter Alexander Ljubenkov · University Of California, San Francisco · R01 · FY2021 · AG
Behavioral Pharmacology of Cannabinoid and Terpenoid Effects and Interactions
$677,123Ryan G Vandrey · Johns Hopkins University · R01 · FY2021 · DA
Modeling hyperactivity in neurological disease using patient-derived pluripotent stem cells
$677,095Fred H Gage · University Of Pennsylvania · U19 · FY2018 · MH
Schizophrenia interactome mapping and global discovery of brain splice variants
$677,081Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2012 · MH
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
$677,076Michael Stephen Trent · University Of Georgia · R01 · FY2023 · AI
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$677,072Layton Harris Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG